Abstract
Atrophy of the stria vascularis and spiral ligament and an associated decrease in the endocochlear potential (EP) are significant factors in age-related hearing loss (presbyacusis). To model this EP decrease, furosemide was delivered into the round-window niche of young adult gerbils by osmotic pump for seven days, chronically reducing the EP by 30–40 mV. Compound action potential (CAP) thresholds were correspondingly reduced by 30–40 dB SPL at high frequencies. Two weeks after withdrawal of furosemide, the treated ears showed an EP recovery of up to 20–30 mV along with a similar recovery of CAP thresholds. The influence of cell division on furosemide-induced and age-related decline of the EP was examined using a mitotic tracer, bromodeoxyuridine (BrdU). Cell proliferation was examined in three groups: young control, furosemide-treated, and aged cochleas. Sections immunostained for BrdU were bleached with H2O2 to eliminate ambiguities with melanin pigment in the inner ear. Cell types positively labeled for BrdU in all three groups included Schwann cells in Rosenthal's canal; glial cells in the osseous spiral lamina; fibrocytes in the limbus, sacculus, and spiral ligament (SL); epithelial cells in Reissner's and round-window membranes; intermediate cells in the stria vascularis; and vascular endothelial cells. Quantitative analysis showed that the mean number of BrdU-positive (BrdU+) intermediate cells in the stria did not differ significantly among the three groups. In contrast, there was a significant increase of BrdU + fibrocytes in the SL of furosemide-treated animals as compared to the young control group. Moreover, there was a significant decrease in labeled fibrocytes in the aged versus the young ears, particularly among the type II and type IV subtypes. The results suggest that the increased fibrocyte turnover in the SL after furosemide treatment may be related to the recovery of EP and CAP thresholds, supporting the hypothesis that fibrocyte proliferation may be essential for maintaining the EP and cochlear function in normal and damaged cochleas. Moreover, the decreased turnover of SL fibrocytes with age may be a contributing factor underlying the lateral wall pathology and consequent EP loss that often accompanies presbyacusis.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
INTRODUCTION
An important factor in the onset of age-related hearing loss is degeneration of the spiral ligament and stria vascularis within the lateral wall of the cochlea (Schuknecht and Gacek 1993; Spicer et al. 1997). The degeneration of these tissues leads to a decrease of the endocochlear potential (EP) which in turn raises hearing thresholds especially at high frequencies (Sewell 1984; Schulte and Schmiedt 1992; Schmiedt and Schulte 1992; Gratton et al. 1996, 1997; Schmiedt et al. 2000, 2002). Furosemide blocks the secretory Na–K–2Cl− cotransporter (NKCC1) and decreases the EP (Forge 1976; Rybak 1985; Ikeda et al. 1997). We have developed a young-gerbil model of presbyacusis by using an osmotic pump to deliver furosemide chronically to one cochlea (Schmiedt et al. 1999, 2000, 2002; Schmiedt and Lang 2001). The physiological results presented here demonstrate that hearing thresholds in the furosemide-treated gerbils can recover to almost normal after cessation of the chronic infusion. The recovery process is novel and its basis is unknown.
Furosemide is thought to block ion transport in those cells in the lateral wall that are known to express NKCC1 (Crouch et al. 1997; Sakaguchi et al. 1998), like certain subtypes of fibrocytes in the spiral ligament and marginal cells in the stria vascularis. The fibrocytes and marginal cells play an important role in regulating ion homeostasis in the cochlea and critically support the generation of the EP. Fibrocytes in the spiral ligament have been classified into five types according to their location, morphology, and histochemical properties (Spicer and Schulte 1991, 1996). Moreover, subclasses of these fibrocytes are known to degenerate with age (Spicer et al. 1997; Sakaguchi et al. 1998; Hequembourg and Liberman 2001).
Roberson and Rubel (1994) and Yamashita et al. (1999) have shown that spiral ligament fibrocytes undergo mitosis in response to acoustic trauma and aminoglycoside insult in young gerbils and mice, respectively. Consideration of the above results led to the hypothesis that the recovery of the EP and hearing thresholds after furosemide treatment might be related to the ability of the affected cells to proliferate after injury. In this article we address this question by assessing change in cell proliferation under conditions of chronic furosemide treatment and senescence.
MATERIALS AND METHODS
Animal and surgical procedures
Mongolian gerbils were born and raised in a low-noise environment where the median sound level was 40 dB SPL. Both genders were used in these experiments. Six gerbils at 35–37 months of age were used in the quiet-age group. For the furosemide group, 16 six-month-old animals were implanted with Alzet® mini-osmotic pumps (model 2004, Durect, Cupertino, CA) and cannulas leading to the right ear. Untreated left ears were used as controls. These pumps have a fill volume of about 200 µl and a mean pumping rate of 0.25 µl/h at 37°C. Cannulas were made up of surgical-grade silicon tubing. Pumps were filled with 5 or 10 mg/ml furosemide under sterile conditions and allowed to equilibrate at 37°C for 36–48 h before implantation.
Surgery for pump implantation was done under sterile conditions. Animals were anesthetized with sodium pentobarbital (50 mg/kg) and were given atropine (0.2 mg/kg) to reduce the respiratory secretions. The pump was placed subdermally behind the scapulae and the cannula routed to the bulla. The cannula was threaded through holes in the bulla and into the round-window niche. The surface of the bulla was then sealed with dental cement. Pumps were left implanted for one week. None of the animals showed any signs of infection. The aged animals and some of the furosemide-treated gerbils were injected with single daily intraperitoneal doses of bromodeoxyuridine (BrdU, 100 mg/kg, Sigma) for four days before sacrifice. Timelines of the BrdU injections are shown in Figure 1. The animal procedures and facilities have full AAALAC and local IACUC accreditation and meet NIH guidelines for animal care.
Physiological procedures
The procedures for recording the CAP response and EP have been described previously (Schmiedt and Zwislocki 1977; Hellstrom and Schmiedt 1996; Schmiedt 1996; Schmiedt et al. 1996). The animal was anesthetized with sodium pentobarbital (50 mg/kg) and fitted to a head holder in a sound- and vibration-isolated booth. The booth was heated to maintain the cochlea at near body temperature (36–37°C). The pinna and surrounding tissues were removed and the bulla opened widely. The CAP electrode was placed on the bony rim of the round-window niche, and the acoustic assembly, comprising a probe-tube microphone (B&K 4134, Bruel and Kjaer, Norcross, GA) and driver (Beyer DT-48, Beyerdynamic, Farmingdale, NY), was sealed to the bony ear canal with closed-cell foam. The tone pips were generated in the frequency domain by TDT (Tucker Davis Technologies, Gainesville, FL) equipment and software, and the spectrum was normalized to the average ear canal SPL obtained from 30 gerbils. CAP thresholds were obtained visually at half-octave frequencies from 0.5 to 16 kHz and at 20 kHz with tone pips of 1.8 ms total duration with cos2 rise/fall times of 0.55 ms. Endocochlear potentials were recorded in cochlear turn 1 (T1), corresponding to a best frequency of about 16 kHz according to the single-fiber map of Müller (1996). EP microelectrodes were filled with 0.2 M KCl and had impedances ranging between 20 and 40 MΩ. The EP was defined as the voltage difference between scala media and a pool of isotonic saline on the neck muscles. Electrode potentials were zeroed after each measure of EP. The timeline of the terminal physiological measures are also shown in Figure 1.
Morphological procedures
Anesthetized animals were perfused via cardiac catheter with 10 ml of normal saline containing 0.1% sodium nitrite followed by 50 ml of 4% paraformaldehyde in PBS. After piercing the round-window membrane, 1 ml of fixative solution was gently perfused through the oval window. The temporal bones were then rapidly harvested and fixed for 6–8 h; then they were decalcified with EDTA, dehydrated, embedded in paraffin, and sectioned serially at 5 µm thickness for immunostaining.
Light microscopic immunostaining for BrdU on every fifth section was performed following previously described procedures (Lang et al. 2000). The tissue sections were deparaffinized, dehydrated, and immersed in a 1% hydrogen peroxide/50% methanol solution for 30 min at room temperature to inactivate endogenous peroxidase. Tissues were treated with 100 µg/ml pepsin in 0.01 N HCl for 25 min at 37°C to unmask aldehyde crosslinked antigens. The sections were denatured with 2 N HCl in 0.05% Tween-20 in PBS for 30 min at 37°C, neutralized in 0.1 M sodium borate (pH 8.5) for 10 min, and immersed in blocking solution for 20 min. Sections were incubated overnight with a mouse anti-BrdU antibody (Sigma-Aldrich, St. Louis, MO) diluted 1:1000 in PBS at 4°C. The secondary antibody was biotinylated antimouse IgG (1:150, Vector Laboratories, Burlingame, CA) and binding was detected with the avidin–biotin–horseradish peroxidase (HRP) technique using the Vectastain (Vector Laboratories, Burlingame, CA) ABC kit. HRP was visualized with 3,3′-diaminobenzidine tetrahydrochloride (DAB).
To bleach the melanocytes, the sections were incubated with 10% H2O2 in PBS for 72 h at room temperature after BrdU immunostaining. Nuclei were counterstained with hematoxylin. BrdU+ cells were counted in every fifth section along the complete length of the cochlea. The total number of BrdU+ cells per ear was obtained by multiplying the actual counts by 5 and dividing by a correction factor of 1.3. The correction factor was determined as described previously (Hall 1990; Hall and Massengill 1997). The number of animals used for immunostaining studies is indicated in Figure 1. Sections were examined on a Zeiss Axioskop (Carl Zeiss, Jena, Germany) light microscope, and photographs were taken using a SPOT digital camera (Diagnostic Instruments, Sterling Heights, MI).
Five sections of the spiral ligament were sampled in the first turn of each cochlea to estimate cell density in the spiral ligaments. The number of type II and IV fibrocytes were counted in each section over an area of 100 µm × 170 µm and then normalized to mm2 area (Fig. 9A).
RESULTS
Physiology
CAP thresholds and EP values obtained from ears used in the BrdU studies are shown in Figure 2. The mean thresholds of control ears (untreated left ears) are typical of data obtained from young gerbils in our lab, as is the mean control EP of 94 mV as measured in the basal turn (T1). Mean data from six ears exposed to furosemide for seven days are plotted along with mean data from four ears allowed to recover from the furosemide treatment for two weeks. The EP reduction induced by furosemide resulted in a constant threshold shift of about 20 dB at frequencies below about 4 kHz, with increasing shifts at higher frequencies. The resulting profiles of CAP thresholds after furosemide treatment are similar to those previously reported in the quiet-aged gerbil (Schmiedt et al. 1990; Schmiedt 1993; Hellstrom and Schmiedt 1990, 1996). Ears allowed to recover for two weeks after furosemide treatment had thresholds similar to the mean control data except at the highest frequencies tested. The recovery of CAP thresholds above 4 kHz paralleled the recovery of the EP to near-normal values after furosemide treatment.
Histochemistry
Melanin bleaching of the inner ear
Following routine immunostaining procedures, numerous melanosomes and abundant melanin pigment were present in most sections of the stria vascularis (Fig. 3A), spiral ligament, modiolus, osseous spiral lamina, macula, ampulla, and semicircular canals and around the endolymphatic duct and sac in all three groups. Similar results have been seen for most other pigmented mammalian species (Wolff 1931; Savin 1965; La Ferriere et al. 1974; Hilding and Ginzberg 1977; Franz et al. 1990; Gratton and Wright 1992). There was a significant increase of melanin pigment in the stria vascularis, spiral ligament, and maculae of the aged inner ear (data not shown). However, there were no discernable changes in the level of melanin pigment in the furosemide-treated group as compared to young controls (data not shown). The large accumulations of melanin pigments in melanosomes were difficult to distinguish from the reaction product associated with BrdU immunostaining. To remedy this ambiguity, melanin pigment was effectively bleached by 10% H2O2 (see Materials and Methods and Fig. 3). This procedure did not alter intensity of the oxidized DAB reactive product (Li et al. 1999). The results for BrdU immunostaining reported below were performed on sections bleached in this manner.
Qualitative observations of cell division
Over 3400 sections from six furosemide-treated, six control, and five quiet-aged ears were examined in this study. The sections included the cochlea, the vestibular labyrinth, and the endolymphatic duct and sac. BrdU incorporation was seen in several cell types in all three groups of ears. These included Schwann cells in Rosenthal's canal; glial cells in the osseous spiral lamina; fibrocytes in the spiral ligament, limbus, and sacculus; epithelial cells in Reissner's and round-window membranes; intermediate cells in the stria vascularis (Figs. 3,4,5); and vascular endothelial cells (data not shown). Only a few nuclei in each ear (1–20) were labeled by the BrdU in most of these cell types, with the exception of fibrocytes in the spiral ligament. Labeled fibrocytes in the ligament were far more numerous than other cell types in all three groups of animals. No BrdU+ cells were seen in the neurosensory or supporting cells of the cochlea and vestibular end organs, in marginal and basal cells of the stria vascularis, nor in epithelial cells of the endolymphatic duct and sac.
Quantitative analysis of cell division
Figure 6A shows the mean number of BrdU+ intermediate cells in the striae obtained from six furosemide-treated, six young control, and five aged animals. There were no significant differences among the three groups (one factor ANOVA, p > 0.05).
On the other hand, as shown in Figure 6B, there was a significant increase in the number of BrdU+ fibrocytes in the spiral ligaments of furosemide-treated animals as compared to the young control group (one factor ANOVA, p < 0.01). The mean number of labeled fibrocytes in the spiral ligament of the furosemide-treated ears was 448.3 ± 108, approximately four times that of the young controls ears (110 ± 20.5). There was also a significant decrease in the number of BrdU+ fibrocytes in the aged group (42 ± 9.3) as compared to young controls (one factor ANOVA, p < 0.01).
Fibrocytes in the spiral ligament have been classified into subtypes based on their location, morphology, and histochemical properties (Spicer and Schulte 1991, 1996). The locations of these subtypes are illustrated in Figure 7. Given the significant differences in cell proliferation observed among the three groups of animals, subtypes of fibrocytes were further analyzed with respect to changes with furosemide treatment and age. The results are shown in Figure 8. The numbers of mitotic cells per ear in all subtypes were significantly greater in furosemide-treated ears as compared to young controls. Differences with age, however, were only statistically significant for type II and type IV fibrocytes (Figs. 8A, B; ANOVA, p < 0.05).
Cell density is not taken into account in the data shown in Figures 6 and 8. A well-known consequence of aging is that cell numbers decline in many organs, including the cochlea. Thus, perhaps the differences in cell proliferation among the three animal groups seen above are caused by differences in cell density. To test this hypothesis, the densities of types II and IV fibrocytes in the lateral wall were determined for the three groups of animals (Fig. 9A). Indeed, there was a significant decrease in the cell density of type II and IV fibrocytes in aged ears as compared to young controls (ANOVA, p < 0.01); however, there was no significant difference between furosemide-treated ears and young controls.
The raw numbers of mitotic type II and IV fibrocytes were normalized to their respective densities by dividing the average number of BrdU+ cells per ear (Fig. 8B) by the respective cell density (Fig. 9A). As shown in Figure 9B, there was still a significant decrease in the mitotic index of type II and IV fibrocytes in the aged ear as compared to young controls (ANOVA, p < 0.05). There was also a significant increase in the normalized BrdU+ index of type II and IV fibrocytes in the furosemide-treated animals as compared to young controls (ANOVA, p < 0.05). Thus, the significant differences seen in Figures 6 and 8 do not change when cell densities among the animal groups are taken into account.
DISCUSSION
Cell division in the ear
Ruben (1967) demonstrated with an radioautographic study in CBA-J mice that cell mitosis continued at least through postnatal day 7 (the oldest animal examined) in the stria vascularis, spiral ligament, Schwann cells, limbal stroma, and the epithelia of the basilar and Reissner's membranes. Roberson and Rubel (1994) observed dividing cells in the stria vascularis, glial cells among acoustic nerve fibers, and the spiral ligament of the 21-day-old gerbil. Cell division also has been reported in the spiral ligament of 4–5-week-old mice (Yamashita et al. 1999). Intermediate cells labeled by BrdU or 3H-thymidine have been seen in guinea pig aged 2–6 months (Conlee et al. 1994). To our knowledge this is the first study of general cell proliferation within the inner ear of mammals older than 6 months of age. The results demonstrate that several types of cells in the gerbil inner ear can continue to divide into old age. These cell types included the intermediate cells of the stria vascularis; glial cells among auditory nerve fibers; Schwann cells in Rosenthal canal; fibrocytes in the spiral ligament, limbus, and sacculus; and epithelial cells lining Reissner's and the round-window membranes.
Effects of chronic furosemide treatment
Many 3H-thymidine- or BrdU-labeled nuclei have been reported in the spiral ligament of the cochlea after acoustic or dihydrostreptomycin-mediated injuries (Roberson and Rubel 1994; Yamashita et al. 1999). A main finding here is that furosemide, when applied chronically to the round window of the gerbil cochlea, can significantly increase the proliferation of fibrocytes in the spiral ligament. Furosemide is a selective inhibitor of NKCC1 and, when administrated systemically, promotes ultrastructural changes in the stria vascularis and a reversible decrease in the EP (Forge 1976; Sewell 1984; Rybak 1985). In this study, chronic furosemide treatment for one week decreased EP to about 30 mV lower than that found in the normal control cochlea. Ultrastructural studies of similarly treated ears showed increased interstitial space surrounding intermediate cells and intermediate cell degeneration in the stria vascularis. But little atrophy was found in spiral ligament (Okamura et al. 2000). The increase of fibrocyte proliferation in the spiral ligament found in this study may reflect a coping response of the cochlea, i.e., an effort to maintain the EP at a physiological level in the presence of furosemide (Schmiedt et al. 2002).
EP recovery after furosemide treatment and fibrocyte proliferation in the spiral ligament
Like some cells in other connective tissues, fibrocytes have the capacity to divide over their lifetime. However, the functional roles of fibrocytes in the inner ear are not fully understood. One hypothesis is that fibrocytes in the spiral ligament help maintain inner-ear ion and fluid homeostasis (Takahashi and Kimura 1970; Schulte and Adams 1989; Spicer and Schulte 1991; 1996; Spicer et al. 1997). Several enzymes involved in ion transport have been shown to be differentially expressed in the various subtypes of spiral ligament fibrocytes. These enzymes include NKCC1, Na,K–ATPase, creatine kinase isozyme BB (CK), and carbonic anhydrase isozyme II (CA) (Schulte and Adams 1989; Spicer and Schulte 1991; Crouch et al. 1997; Spicer et al. 1997; Sakaguchi et al. 1998). Gap junctions are present among the fibrocytes and, along with the ion-transporter enzymes, are thought to play an active role in K+ recycling in the ear (Kikuchi et al. 1995; 2000; Spicer and Schulte 1996). Moreover, Minowa and colleagues (1999) have demonstrated that the POU3F4 mouse mutant has a reduced EP associated with ultrastructural abnormalities in spiral ligament fibrocytes, providing additional evidence that these cells are fundamental to normal cochlear function.
Here, ears that were allowed to recover for two weeks after chronic furosemide application reacquired significant function with regard to EP values and CAP thresholds. Recovery after acute systemic treatment with furosemide takes only a few minutes or hours (Forge 1976; Sewell 1984; Rybak 1985; Ikeda et al. 1997). However, EP and CAP measures in our lab showed little recovery 6–24 h after chronic treatment (data not shown). Compared with previous acute experiments, the chronic furosemide model can provide relatively long periods of moderate EP reduction. The moderate reduction may be the trigger for increasing the proliferation of fibrocytes in the spiral ligament as a self-protective reaction or homeostatic mechanism to regain normal values of EP.
Intermediate cell proliferation
Roberson and Rubel (1994) reported that cell division was enhanced in the stria vascularis of the developing gerbil after acoustic trauma. Basal, marginal, intermediate, and capillary endothelial cells were all seen to divide. Cell proliferation was especially apparent in regions where damage to the organ of Corti was most severe. Thus, with acoustic trauma, the increased proliferation extended to many cell types and presumably represented an attempt to repair damaged tissue. Our results with furosemide treatment differ from those produced by acoustic trauma. While intermediate cells showed low rates of cell division in control tissue, this rate did not increase after furosemide treatment. Only spiral ligament fibrocytes significantly increased their turnover rate after treatment. Thus, cell proliferation in the cochlea seems dependent on the specific trauma involved as well as, perhaps, its mechanism of delivery and duration.
Caution must be used in quantifying proliferation among intermediate cells. Increased pigmentation in the stria has been observed in many studies after cochlear trauma (Gratacap et al. 1985; Gratton and Wright 1992; Shaddock et al. 1985). The melanosomes and melanin pigment can easily be mistaken for positive staining with BrdU and even with radioautographic techniques, making the counting of dividing cells problematic. We found it imperative to bleach the stria vascularis to get a true estimate of intermediate cell division. To our knowledge, bleaching the stria vascularis has not been done in previous studies.
Type II and type IV fibrocytes in the aged ear
Another important finding was the significant decrease in fibrocyte proliferation found in the spiral ligament of the aged cochlea. Decreased mitosis was significant only in type II and IV fibrocytes. Decreased turnover of spiral ligament fibrocytes may be related to the decrease of ion-transport enzymes found in the lateral wall of aged animals. For example, Na,K–ATPase immunostaining is significantly reduced in type II and IV fibrocytes in aged cochleas (Schulte and Schmiedt 1992; Spicer et al. 1997). Decreased cell turnover in type II and IV fibrocytes could lead to fewer surviving cells and could be responsible for the reduced immunostaining for Na,K–ATPase in the spiral ligament of the aged gerbil. Thus, decreased cell proliferation with age may play an essential role in metabolic presbyacusis with its associated loss of EP.
References
JW Conlee LC Gerity ML Bennett (1994) ArticleTitleOngoing proliferation of melanocytes in the stria vascularis of adult guinea pigs. Hear. Res. 79 115–122 Occurrence Handle10.1016/0378-5955(94)90133-3 Occurrence Handle1:STN:280:ByqC3crht1M%3D Occurrence Handle7806474
JJ Crouch N Sakaguchi C Lytle BA Schulte (1997) ArticleTitleImmunohistochemical localization of the Na–K–Cl co-transporter (NKCC1) in the gerbil inner ear. J. Histochem. Cytochem. 45 773–778 Occurrence Handle1:CAS:528:DyaK2sXjs1ahsLs%3D Occurrence Handle9199662
A Forge (1976) ArticleTitleObservations on the stria vascularis of the guinea pig cochlea and the changes resulting from the administration of the diuretic furosemide. Clin. Otolaryngol. 1 211–219 Occurrence Handle1:STN:280:CSeD2c3js1Y%3D Occurrence Handle1031348
P Franz S Aharinejad W Firbas (1990) ArticleTitleMelanocytes in the modiolus of the guinea pig cochlea. Acta Otolaryngol. 109 221–227 Occurrence Handle1:STN:280:By%2BC1MrlslQ%3D Occurrence Handle2316345
B Gratacap R Charachon P Stoebner (1985) ArticleTitleResults of an ultrastructural study comparing stria vascularis with organ of Corti in guinea pigs treated with kanamycin. Acta Otolaryngol. (Stockh.) 99 339–342 Occurrence Handle1:STN:280:BiqB2cjlsVQ%3D
MA Gratton CG Wright (1992) ArticleTitleHyperpigmentation of chinchilla stria vascularis following acoustic trauma. Pigment. Cell. Res. 5 30–37 Occurrence Handle1:STN:280:By2A3srht10%3D Occurrence Handle1631019
MA Gratton RA Schmiedt BA Schulte (1996) ArticleTitleAge-related decreases in the endocochlear potential are associated with vascular abnormalities in the stria vascularis. Hear. Res. 102 181–190 Occurrence Handle10.1016/S0378-5955(96)00130-X Occurrence Handle1:STN:280:ByiC3cbhvVU%3D Occurrence Handle8951461
MA Gratton BA Schulte NM Smythe (1997) ArticleTitleQuantification of the stria vascularis and strial capillary areas in quiet-reared young and aged gerbils. Hear. Res. 114 IssueID1-2 1–9 Occurrence Handle10.1016/S0378-5955(97)00025-7 Occurrence Handle1:STN:280:DyaK1c7gslKjsA%3D%3D Occurrence Handle9447913
RD Hall (1990) ArticleTitleEstimation of surviving spiral ganglion cells in the deaf rat using the electrically evoked auditory brainstem response. Hear. Res. 45 123–136 Occurrence Handle10.1016/0378-5955(90)90188-U Occurrence Handle1:STN:280:By%2BB28vitVc%3D Occurrence Handle2345111
RD Hall JL Massengill (1997) ArticleTitleThe number of primary auditory afferents in the rat. Hear. Res. 103 75–84 Occurrence Handle10.1016/S0378-5955(96)00166-9 Occurrence Handle1:STN:280:ByiC28%2Fgs1Q%3D Occurrence Handle9007576
LI Hellstrom RA Schmiedt (1990) ArticleTitleCompound action potential input/output functions in young and quiet-aged gerbils. Hear. Res. 50 163–174 Occurrence Handle10.1016/0378-5955(90)90042-N Occurrence Handle1:STN:280:By6C28bpsF0%3D Occurrence Handle2076969
LI Hellstrom RA Schmiedt (1996) ArticleTitleMeasures of tuning and suppression in single-fiber and whole-nerve responses in young and quiet-aged gerbils. J. Acoust. Soc. Am. 100 3275–3285 Occurrence Handle1:STN:280:ByiD2s7jvVE%3D Occurrence Handle8914310
S Hequembourg MC Liberman (2001) ArticleTitleSpiral ligament pathology: a major aspect of age-related cochlear degeneration in C57BL/6 mice. J. Assoc. Res. Otolaryngol. 02 118–129 Occurrence Handle1:STN:280:DC%2BD3MrgtFansg%3D%3D
DA Hilding RD Ginzberg (1977) ArticleTitlePigmentation of the stria vascularis. The contribution of neural crest melanocytes. Acta Otolaryngol. (Stockh.) 84 24–37 Occurrence Handle1:STN:280:CSiB28zgs1E%3D
K Ikeda T Oshima H Hidaka T Takasaka (1977) ArticleTitleMolecular and clinical implications of loop diuretic ototoxicity. Hear. Res. 107 1–8 Occurrence Handle10.1016/S0378-5955(97)00009-9
T Kikuchi RS Kimura DL Paul JC Adams (1995) ArticleTitleGap junctions in the rat cochlea: immunohistochemical and ultrastructural analysis. Anat. Embryol. (Berl.) 191 101–118 Occurrence Handle1:STN:280:ByqB2czks1A%3D
T Kikuchi RS Kimura DL Paul T Takasaka JC Adams (2000) ArticleTitleGap junction systems in the mammalian cochlea. Brain. Res. Brain. Res. Rev. 32 163–166 Occurrence Handle10.1016/S0165-0173(99)00076-4 Occurrence Handle1:CAS:528:DC%2BD3cXit1Whtbo%3D Occurrence Handle10751665
KA La Ferriere IK Arenberg JE Hawkins LG Johnsson (1974) ArticleTitleMelanocytes of the vestibular labyrinth and their relationship to the microvasculature. Ann. Otol. Rhinol. Laryngol. 83 685–694 Occurrence Handle1:STN:280:CSqD3M3lvVI%3D Occurrence Handle4606802
H Lang MM Bever DM Fekete (2000) ArticleTitleCell proliferation and cell death in the developing chick inner ear: spatial and temporal patterns. J. Comp. Neurol. 417 205–220 Occurrence Handle10.1002/(SICI)1096-9861(20000207)417:2<205::AID-CNE6>3.0.CO;2-Y Occurrence Handle1:STN:280:DC%2BD3c7is1Ogtw%3D%3D Occurrence Handle10660898
LX Li KA Crotty JJ Kril AA Palmer SW McCarthy (1999) ArticleTitleMethod of melanin bleaching in MIB1-Ki67 immunostaining of pigmented lesions: A quantitative evaluation in malignant melanomas. Histochem. J. 131 237–240
O Minowa K Ikeda Y Sugitani T Oshima S Nakai Y Katori M Suzuki M Furukawa T Kawase Y Zheng M Ogura Y Asada K Watanabe H Yamanaka S Gotoh M Nishi–Takeshima T Sugimoto T Kikuchi T Takasaka T Noda (1999) ArticleTitleAltered cochlear fibrocytes in a mouse model of DFN3 nonsyndromic deafness [see comments]. Science 285 1408–1411 Occurrence Handle10.1126/science.285.5432.1408 Occurrence Handle1:CAS:528:DyaK1MXlslaqur0%3D Occurrence Handle10464101
M Müller (1996) ArticleTitleThe cochlear place–frequency map of the adult and developing Mongolian gerbil. Hear Res. 94 148–156 Occurrence Handle10.1016/0378-5955(95)00230-8 Occurrence Handle8789820
H Okamura RA Schmiedt S Spicer B Schulte (2000) ArticleTitleMorphologic and physiologic changes in gerbil cochleas induced by chronic exposure to furosemide. Assoc. Res. Otolaryngol. Abstr. 23 126
D Roberson EW Rubel (1994) ArticleTitleCell division in the gerbil cochlea after acoustic trauma. Am. J. Otol. 15 IssueID1 28–34 Occurrence Handle1:STN:280:ByuC2M3mvF0%3D Occurrence Handle8109626
RJ Ruben (1967) ArticleTitleDevelopment of the inner ear of the mouse: a radioautographic study of terminal mitoses. Acta Otolaryngol. Suppl. (Stockh.) 220 1–44
LP Rybak (1985) ArticleTitleFurosemide ototoxicity: clinical and experimental aspects. Laryngoscope 95 1–14 Occurrence Handle1:STN:280:BiqB1MrhsFE%3D
N Sakaguchi JJ Crouch C Lytle BA Schulte (1998) ArticleTitleNa–K–Cl cotransporter expression in the developing and senescent gerbil cochlea. Hear. Res. 118 114–122 Occurrence Handle10.1016/S0378-5955(98)00022-7 Occurrence Handle1:CAS:528:DyaK1cXivFWku7k%3D Occurrence Handle9606066
C Savin (1965) ArticleTitleThe blood vessels and pigmentary cells of the inner ear. Ann. Otol. Rhinol. Laryngol. 74 611–623 Occurrence Handle1:STN:280:CCmD2cnltlM%3D Occurrence Handle5846531
RA Schmiedt (1993) Does the aging cochlea need a jump-start? RT Verrillo (Eds) Sensory Research Multimodal Perspectives. Erlbaum and Associates New York 91–103
RA Schmiedt (1996) ArticleTitleEffects of aging on potassium homeostasis and the endocochlear potential in the gerbil cochlea. Hear. Res. 102 125–132 Occurrence Handle10.1016/S0378-5955(96)00154-2 Occurrence Handle1:CAS:528:DyaK2sXisFKhtg%3D%3D Occurrence Handle8951457
RA Schmiedt JJ Zwislocki (1997) ArticleTitleComparison of sound-transmission and cochlear-microphonic characteristics in Mongolian gerbil and guinea pig. J. Acoust. Soc. Am. 61 133–149
RA Schmiedt BA Schulte (1992) Physiologic and histopathologic changes in quiet- and noise-aged gerbil cochleas. A Dancer D Henderson R Salvi R Hamernik (Eds) Noise Induced Hearing Loss Mosby Yearbook Inc. St. Louis, MO 246–256
RA Schmiedt H Lang (2001) ArticleTitlePresbyacusic thresholds: a consequence of an energy-starved cochlear amplifier. Assoc. Res. Otolaryngol. Abstr. 24 148
RA Schmiedt JH Mills JC Adams (1990) ArticleTitleTuning and suppression in auditory nerve fibers of aged gerbils raised in quiet or noise. Hear. Res. 45 221–236 Occurrence Handle10.1016/0378-5955(90)90122-6 Occurrence Handle1:STN:280:By%2BB1M3ptlI%3D Occurrence Handle2358415
RA Schmiedt JH Mills FA Boettcher (1996) ArticleTitleAge-related loss of activity of auditory-nerve fibers. J. Neurophysiol. 76 799–803 Occurrence Handle8871200
RA Schmiedt SS Spicer BA Schulte (1999) ArticleTitleMorphologic and physiologic changes in gerbil cochleas exposed to chronic infiltration of furosemide into perilymph. Assoc. Res. Otolaryngol. Abstr. 22 134
RA Schmiedt H Lang H Okamura (2000) ArticleTitleModel of metabolic presbyacusis: Neural responses under condition of chronically-low endocochlear potentials induced with furosemide. Assoc. Res. Otolaryngol. Abstr. 23 282
RA Schmiedt H Lang H Okamura BA Schulte (2002) ArticleTitleEffects of furosemide applied chronically to the round window: a model of metabolic presbyacusis. J. Neurosci. 22 9643–9650 Occurrence Handle1:CAS:528:DC%2BD3sXmsVGmtbo%3D Occurrence Handle12417690
HF Schuknecht MR Gacek (1993) ArticleTitleCochlear pathology in presbyacusis. Ann. Otol. Rhinol. Laryngol. 102 1–16 Occurrence Handle1:STN:280:ByyC38fotlM%3D
BA Schulte JC Adams (1989) ArticleTitleDistribution of immunoreactive Na+,K+–ATPase in gerbil cochlea. J. Histochem. Cytochem. 37 127–134 Occurrence Handle1:CAS:528:DyaL1MXpt1Cruw%3D%3D Occurrence Handle2536055
BA Schulte RA Schmiedt (1992) ArticleTitleLateral wall Na,K–ATPase and endocochlear potentials decline with age in quiet-reared gerbils. Hear. Res. 61 35–46 Occurrence Handle10.1016/0378-5955(92)90034-K Occurrence Handle1:CAS:528:DyaK38XlvVyrurY%3D Occurrence Handle1326507
W Sewell (1984) ArticleTitleThe effects of furosemide on the endocochlear potential and auditory-nerve fiber tuning curves in cats. Hear. Res. 14 305–314 Occurrence Handle10.1016/0378-5955(84)90057-1 Occurrence Handle1:CAS:528:DyaL2cXlsVersbw%3D Occurrence Handle6480516
LC Shaddock CG Wright RP Hamernik (1985) ArticleTitleA morphometric study of microvascular pathology following experimental rupture of Reissner's membrane. Hear. Res. 20 119–129 Occurrence Handle10.1016/0378-5955(85)90163-7 Occurrence Handle1:STN:280:BimC3M7jsVc%3D Occurrence Handle4086379
SS Spicer BA Schulte (1991) ArticleTitleDifferentiation of inner ear fibrocytes according to their ion transport related activity. Hear. Res. 56 53–64 Occurrence Handle10.1016/0378-5955(91)90153-Z Occurrence Handle1:STN:280:By2C387gsVc%3D Occurrence Handle1663106
SS Spicer BA Schulte (1996) ArticleTitleThe fine structure of spiral ligament cells relates to ion return to the stria and varies with place-frequency. Hear. Res. 100 80–100 Occurrence Handle10.1016/0378-5955(96)00106-2 Occurrence Handle1:STN:280:ByiD1c7ntl0%3D Occurrence Handle8922982
SS Spicer MA Gratton BA Schulte (1997) ArticleTitleExpression patterns of ion transport enzymes in spiral ligament fibrocytes change in relation to strial atrophy in the aged gerbil cochlea. Hear. Res. 111 93–102 Occurrence Handle10.1016/S0378-5955(97)00097-X Occurrence Handle1:CAS:528:DyaK2sXmtlCqtr8%3D Occurrence Handle9307315
T Takahashi RS Kimura (1970) ArticleTitleThe ultrastructure of the spiral ligament in the Rhesus monkey. Acta Otolaryngol. (Stockh.) 69 46–60 Occurrence Handle1:STN:280:CS%2BC1M%2Fmt1A%3D
D Wolff (1931) ArticleTitleMelanin in inner ear. Arch. Otolaryngol. 14 195–211
H Yamashita H Shimogori K Sugahara M Takahashi (1999) ArticleTitleCell proliferation in spiral ligament of mouse cochlea damaged by dihydrostreptomycin sulfate. Acta Otolaryngol. 119 322–325 Occurrence Handle10.1080/00016489950181323 Occurrence Handle1:STN:280:DyaK1MzgvVCnsQ%3D%3D Occurrence Handle10380736
Acknowledgements
The authors thank Boo Schmiedt and Nancy Smythe for their technical assistance. This work was supported by NIH/NIA RO1 AG/14748 (RAS) and NIH/NIDCD R01 DC00713 (BAS).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lang, H., Schulte, B. & Schmiedt, R. Effects of Chronic Furosemide Treatment and Age on Cell Division in the Adult Gerbil Inner Ear . JARO 4, 164–175 (2003). https://doi.org/10.1007/s10162-002-2056-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10162-002-2056-4